柴芍承气汤联合低分子肝素治疗高脂血症性急性胰腺炎腑实热结证临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R657.5+1

基金项目:

杭州市科技计划引导项目(20211231Y177);浙江中医药大学附属医院科研项目(2023FSYYZY77);浙江省中医药科技计划项目(2023ZL145)


Clinical Study on Chaishao Chengqi Decoction Combined with Low Molecular Weight Heparin for Hypertriglyceridemia-Induced Acute Pancreatitis with Fu-Organ Excess- Heat Accumulation Syndrome
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察柴芍承气汤联合低分子肝素治疗高脂血症性急性胰腺炎(HLAP) 腑实热结证的临床疗 效。方法:将杭州市临安区中医院2023年1月—2024年12月收治的82例HLAP腑实热结证患者按随机数字表 法分为试验组与对照组各41例。2组患者入院后均给予常规对症治疗,对照组在此基础上给予低分子肝素治 疗,试验组在对照组基础上给予柴芍承气汤治疗。2组均治疗7天。比较2组临床疗效及胃肠功能恢复时间,观 察2组治疗前后中医证候积分、炎症因子、血脂指标、胰腺指标及肠黏膜屏障功能指标的变化。结果:治疗 7天后,试验组总有效率92.50%(37/40),高于对照组76.32%(29/38)(P<0.05)。试验组腹痛、腹胀、恶心 呕吐消失时间及首次排气、排便时间均短于对照组(P<0.05)。治疗7天后,2组腹痛、腹胀、大便不通、 胸脘痞塞、恶心呕吐、口干口臭、日晡潮热、小便短赤积分及中医证候总积分均较治疗前降低(P<0.05), 试验组上述8项中医证候积分及中医证候总积分均低于对照组(P<0.05)。治疗7天后,2组血清肿瘤坏死因 子-α(TNF-α)、白细胞介素-6(IL-6)、甘油三酯(TG)、脂肪酶(LPS)、淀粉酶(AMY)、D-乳酸(D-LA)、 二胺氧化酶(DAO)、可溶性晚期糖基化终末产物受体(sRAGE) 及内毒素(ET) 水平均较治疗前降低(P<0.05), 血清白细胞介素-10(IL-10) 水平均较治疗前提高(P<0.05);试验组血清TNF-α、IL-6、TG、LPS、AMY、 D-LA、DAO、sRAGE及ET水平均低于对照组(P<0.05),血清IL-10水平高于对照组(P<0.05)。结论:柴 芍承气汤联合低分子肝素治疗HLAP腑实热结证疗效显著,可有效减轻症状,促进胃肠功能恢复,减轻机体炎 症反应及改善肠黏膜屏障功能。

    Abstract:

    Abstract: Objective: To observe the clinical efficacy of Chaishao Chengqi Decoction combined with low molecular weight heparin(LMWH)in treating hypertriglyceridemia-induced acute pancreatitis(HLAP)with fu-organ excess-heat accumulation syndrome. Methods:A total of 82 HLAP patients with fu-organ excess-heat accumulation syndrome admitted to Hangzhou Lin'an Traditional Chinese Medicine Hospital from January 2023 to December 2024 were divided into the trial group and the control group using the random number table method,with 41 cases in each group. Both groups received conventional treatment,with the control group additionally receiving LMWH and the trial group receiving both LMWH and Chaishao Chengqi Decoction for seven days. Clinical efficacy,gastrointestinal function recovery time between the two groups were compared, traditional Chinese medicine syndrome scores, inflammatory factors, blood lipid indexes, pancreatic indexes, and intestinal barrier function markers before and after treatment between the two groups were compared. Results: After seven days of treatment, the total effective rate in the trial group was 92.50%(37/40),which was higher than the control group's 76.32%(29/38)(P<0.05). The disappearance time of abdominal pain,bloating,nausea and vomiting,as well as the time of first flatus and defecation in the trial group were shorter than those in the control group(P<0.05). After seven days of treatment,the scores of abdominal pain,bloating,constipation,chest congestion,nausea and vomiting,dry mouth and bad breath,hot flashes in the late afternoon, short and red urine, and the total score of traditional Chinese medicine syndromes in both groups decreased compared with those before treatment(P<0.05). The scores of the above eight traditional Chinese medicine syndromes and the total score of traditional Chinese medicine syndromes in the trial group were lower than those in the control group(P<0.05). After seven days of treatment, the levels of serum tumor necrosis factor- α(TNF - α), interleukin-6(IL-6),triglycerides(TG),lipase(LPS),amylase(AMY),D-lactate(D-LA),diamine oxidase (DAO), soluble advanced glycation end product receptor(sRAGE), and endotoxin(ET)in both groups decreased compared to before treatment(P<0.05), while the levels of serum interleukin-10(IL-10)increased compared to before treatment(P<0.05);the serum levels of TNF-α,IL-6,TG,LPS,AMY,D-LA,DAO,sRAGE,and ET in the trial group were lower than those in the control group(P<0.05),while the serum level of IL-10 was higher than that in the control group(P<0.05). Conclusion: Chaishao Chengqi Decoction combined with LMWH significantly improves HLAP with fu-organ excess-heat accumulation syndrome by alleviating symptoms,promoting gastrointestinal recovery,and demonstrating inflammatory reaction-reduce and intestinal barrier-protective mechanisms.

    参考文献
    相似文献
    引证文献
引用本文

卞银燕,徐燕芳,刘贤永.柴芍承气汤联合低分子肝素治疗高脂血症性急性胰腺炎腑实热结证临床研究[J].新中医,2025,57(20):51-57

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-10-31
  • 出版日期:
文章二维码